BamSEC and AlphaSense Join Forces
Learn More

Vistagen Therapeutics Inc. – Material Contracts

NASDAQ: VTGN    
Share price (7/2/26): $0.25    
Market cap (7/2/26): $10.2 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 8 pages Vistagen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 8-K 8 pages Vistagen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.2
from 10-Q 8 pages Consulting Services Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Consulting Services Agreement
12/34/56
EX-10.1
from 8-K 10 pages Vistagen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 8-K 8 pages Vistagen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.163
from 10-K 10 pages Vistagen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.2
from 10-Q 1 page Amendment No. 4 to Consulting Services Agreement Amendment
12/34/56
EX-10.1
from 8-K 6 pages Exclusive Negotiation Agreement
12/34/56
EX-10.162
from 10-K 2 pages Amendment No. 1 to Master Services Agreement (For All Cro Services) Amendment
12/34/56
EX-10.161
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.159
from 10-K 2 pages Amendment No. 3 to Consulting Services Agreement Amendment
12/34/56
EX-10.1
from 10-Q 2 pages Amendment No. 2 to Consulting Services Agreement Amendment
12/34/56
EX-10.3
from 10-Q 7 pages Consulting Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Amendment No. 1 to Consulting Services Agreement Amendment
12/34/56
EX-10.1
from 10-Q 7 pages Consulting Services Agreement
12/34/56
EX-10.1
from 10-Q 6 pages VistaGen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Third Amendment to Lease
12/34/56
EX-10.1
from 8-K 7 pages VistaGen Therapeutics, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 8-K 7 pages VistaGen Therapeutics, Inc. Indemnification Agreement
12/34/56